Health Condition 1: L818- Other specified disorders of pigmentation
Conditions
Interventions
Control Intervention1: NIL: NIL
Sponsors
MV SAI GOUTHAM REDDY
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients presenting with clinical features of ADMH of either gender 2. Patients who are willing to give informed written consent for enrollment into the study.
Exclusion criteria
Exclusion criteria: 1. Patients who are not willing to give consent 2. Patients who had exposure to drugs known to induce hyperpigmentation 3. Other causes of acquired hyperpigmentation, having a preceding inflammatory phase, e.g., fixed drug eruption, prurigo pigmentosa, post-inflammatory hyperpigmentation. 4. Other causes of acquired hyperpigmentation, without interface changes like melasma, amyloidosis and nevoid hypermelanosis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Data from dermoscopic findings of this study will help in diagnosis of acquired pigmentary disorders without invasive procedures like biopsyTimepoint: Baseline | — |
Secondary
| Measure | Time frame |
|---|---|
| This study helps to diagnose acquired dermal macular hyperpigmentation through dermoscopeTimepoint: Baseline | — |
Countries
India
Contacts
Public ContactMV SAI GOUTHAM REDDY
KASTURBA MEDICAL COLLEGE, MANGALORE
Outcome results
None listed